Health Catalyst, Inc. (HCAT)

Health Catalyst Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	53.75	50.81	249.65	106.28	116.31	193.23
Short-Term Investments	25.25	44.92	142.36	211.45	247.18	251.75
Cash & Short-Term Investments	78.99	95.73	392	317.73	363.49	444.98
Cash Growth	-13.71%	-75.58%	23.38%	-12.59%	-18.31%	64.28%
Accounts Receivable	41.33	59.13	57.18	60.29	47.97	48.8
Other Receivables	-	0.3	0.6	0.9	0.6	0.8
Receivables	41.33	59.43	57.78	61.19	48.57	49.6
Prepaid Expenses	12.64	12.35	13.77	12.28	14.24	12.41
Other Current Assets	-	1.8	2.1	2.2	1.5	1.4
Total Current Assets	132.97	169.31	465.65	393.4	427.8	508.39
Property, Plant & Equipment	40.06	40.48	41.45	39.64	42.59	44.45
Goodwill	11.1	209.07	259.76	190.65	185.98	169.97
Other Intangible Assets	50.08	77.68	86.05	73.38	92.19	104.79
Long-Term Deferred Charges	-	2.4	2.9	3.3	2.6	3
Other Long-Term Assets	3.21	3.71	3.12	1.44	1.13	1.5
Total Assets	237.42	502.64	858.93	701.81	752.29	832.1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.53	9.36	11.43	6.64	4.42	4.69
Accrued Expenses	25.85	17.99	26.34	20.93	17.85	23.73
Current Portion of Long-Term Debt	-	1.63	231.18	-	-	-
Current Portion of Leases	3.66	3.78	3.61	3.36	3.43	3.43
Current Unearned Revenue	42.11	56.11	53.28	55.75	54.96	56.63
Other Current Liabilities	-	0.7	-	2.36	1.84	4.58
Total Current Liabilities	78.15	89.57	325.85	89.03	82.51	93.05
Long-Term Debt	-	151.62	151.18	228.03	226.52	180.94
Long-Term Leases	12.09	14.21	16.29	17.68	18.02	20.24
Long-Term Unearned Revenue	1.03	0.41	0.25	0.08	0.11	0.93
Long-Term Deferred Tax Liabilities	-	0.23	0.16	0.07	0.07	-
Other Long-Term Liabilities	0.57	0.82	-0	0	0.06	14.83
Total Liabilities	91.83	256.86	493.72	334.9	327.28	310

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,620	1,609	1,553	1,484	1,425	1,401
Retained Earnings	-1,476	-1,365	-1,187	-1,117	-999.02	-878.86
Comprehensive Income & Other	1.02	1.59	-0.84	0.03	-0.65	-0.07
Total Common Equity	145.59	245.78	365.21	366.92	425.01	522.1
Shareholders' Equity	145.59	245.78	365.21	366.92	425.01	522.1
Total Liabilities & Equity	237.42	502.64	858.93	701.81	752.29	832.1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	15.75	171.24	402.27	249.07	247.97	204.61
Net Cash (Debt)	63.24	-75.51	-10.27	68.66	115.52	240.37
Net Cash Growth	-	-	-	-40.56%	-51.94%	218.01%
Net Cash Per Share	0.86	-1.08	-0.17	1.22	2.14	5.06
Filing Date Shares Outstanding	76.16	73.59	70.21	58.56	55.81	53.35
Total Common Shares Outstanding	76.16	72.03	64.04	58.3	55.26	52.62
Working Capital	54.82	79.73	139.8	304.36	345.29	415.34
Book Value Per Share	1.91	3.41	5.70	6.29	7.69	9.92
Tangible Book Value	84.41	-40.97	19.4	102.88	146.84	247.34
Tangible Book Value Per Share	1.11	-0.57	0.30	1.76	2.66	4.70
Machinery	-	13.82	14.07	13.37	13.75	12.95
Leasehold Improvements	-	6.31	8.46	8.81	9.97	10.83

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error